Meta-analysis of factors for osteonecrosis in systemic lupus erythematosus: integration of comprehensive literatures and multicenter databases - Scorecard - MDSpire
Advertisement
Meta-analysis of factors for osteonecrosis in systemic lupus erythematosus: integration of comprehensive literatures and multicenter databases
Clinical Scorecard: Comprehensive Meta-Analysis of Contributing Factors to Osteonecrosis in Systemic Lupus Erythematosus: A Synthesis of Literature and Multicenter Data
At a Glance
Category
Detail
Condition
Osteonecrosis in Systemic Lupus Erythematosus
Key Mechanisms
Interruption of bone blood flow, bone ischemia, cellular necrosis.
Target Population
Patients with systemic lupus erythematosus (SLE).
Care Setting
Clinical management of SLE patients.
Key Highlights
Osteonecrosis is a prevalent complication in SLE, with a prevalence range of 3% to 44%.
Factors positively related to SLE-ON include neuropsychiatric lupus, hyperlipidemia, and steroid pulse therapy.
Anti-SSA and anti-SSB antibodies are negatively related to SLE-ON susceptibility.
Younger age and age at onset are significantly related to the development of SLE-ON.
Targeted monitoring of modifiable risk factors may help reduce SLE-ON risk.
Guideline-Based Recommendations
Diagnosis
Diagnosis of ON using appropriate imaging or clinical techniques.
Management
Optimized steroid pulse therapy and cyclophosphamide use.
Monitoring & Follow-up
Early osteoporosis screening and risk stratification based on anti-SSA/SSB antibody status.
Risks
High-dose glucocorticoid use, coagulation abnormalities, dyslipidemia, and vasculitis.
Patient & Prescribing Data
Patients with systemic lupus erythematosus (SLE) at risk for osteonecrosis.
Caution advised in the use of cyclophosphamide and steroid pulse therapy due to potential confounding by disease severity.
Clinical Best Practices
Comprehensive identification of factors related to SLE-ON.
Implementation of targeted preventive measures to reduce incidence of ON.
